ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 141

Age and Activity-Dependent Differences in Intraocular Immune Profile of Chronic Autoimmune Uveitis

Eamon Winden1, Maryrose Hahn2, Yang Yang3, Madison Mangin1, Kellen Winden1, Pui Lee4, Mindy Lo3, Yasmin Massoudi5, Tate Valerio5, Amanda Colombo5, Jessica Scott5, Stephen Anesi5, C. Stephen Foster5, Peter Nigrovic6, Bharti Nihalani-Gangwani7, Sheila Angeles-Han8, Peter Chang5 and Margaret Chang4, 1Boston Children’s Hospital, 2Boston Children’s Hospital, Georgetown, MA, 3Boston Children's Hospital, Boston, MA, 4Boston Children's Hospital, Newton, MA, 5Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation, 6Boston Children's Hospital, Brookline, MA, 7Boston Children's Hospital, 8Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, March 21, 2026

Title: Plenary Abstract Session III

Session Time: 11:45AM-12:00PM

Background/Purpose: Autoimmune uveitis is a chronic inflammatory disorder of the eye that often requires lifelong immunosuppression as uveitis relapse occurs in 85% of patients who discontinue medications. However, the pathogenesis of chronic, relapsing eye inflammation is poorly understood. To determine the local mediators of chronic uveitis, we assessed the intraocular cytokine and immune cell profiles within the aqueous humor (AQH) of patient with autoimmune uveitis.

Methods: We obtained AQH samples from adult and pediatric patients with uveitis or non-inflammatory conditions undergoing eye surgery at Boston Children’s Hospital, Massachusetts Eye Research & Surgery Institution and Cincinnati Children’s Hospital Medical Center. We also collected clinical information such as slit-lamp examinations and medications at the time of surgery. Cytokine content of the AQH was assessed through the Olink proximity extension multiplex immunoassay and samples were assigned an Inflammatory Score based on the sum of normalized cytokine values. AQH samples were pooled for 10x single-cell RNA sequencing then de-multiplexed using SNP profiles determined by low-pass whole genome sequencing.

Results: We evaluated AQH samples from controls (n=16) and patients with autoimmune uveitis (n=29). At the time of sample collection, all patients had near-quiet disease activity on slit-lamp examination with anterior chamber cell grades between 0 and 0.5+ by SUN criteria. Non-inflammatory control patients displayed low cytokine levels in their AQH, while 41% of patients with uveitis had elevated inflammatory cytokines (positive Inflammatory Score). Strikingly, >85% of children displayed
a positive Inflammatory Score compared to 28% of adults. Single-cell RNA sequencing of 37 control and uveitis samples revealed distinct immune cell populations associated with patient age and clinical disease activity. Namely, monocyte populations were detected in adult samples while none were detected in pediatric samples. This was supported by proteomic data which showed an association with adult uveitis and myeloid-related inflammatory cytokines. There was no correlation between monocytes and Inflammatory Score. In contrast, the Inflammatory Score correlated with increased CD8⁺ T cell populations, specifically resident memory T cells (TRM), and decreased CD4⁺ T cell populations. Proteomic analysis confirmed a direct correlation between IL-15, which supports CD8+ T cells and TRM survival, and the Inflammatory Score.

Conclusion: Subclinical immune activity is common within the AQH of uveitis patients with clinically inactive disease, an observation that is particularly striking in children. Subclinical activity correlated with an increased TRM cells, known mediators of relapsing autoimmune inflammation, providing a possible pathogenic mechanism to chronic, relapsing ocular inflammation. Further, the intraocular immune profile differed between children and adults, highlighting distinctions between pediatric and adult uveitis that may warrant different considerations in therapeutic approaches.


Disclosures: E. Winden: None; M. Hahn: None; Y. Yang: None; M. Mangin: None; K. Winden: None; P. Lee: None; M. Lo: None; Y. Massoudi: None; T. Valerio: None; A. Colombo: None; J. Scott: None; S. Anesi: None; C. Foster: None; P. Nigrovic: None; B. Nihalani-Gangwani: None; S. Angeles-Han: Cabaletta Bio, 1; P. Chang: None; M. Chang: Attovia therapeutics, 2, 11.

To cite this abstract in AMA style:

Winden E, Hahn M, Yang Y, Mangin M, Winden K, Lee P, Lo M, Massoudi Y, Valerio T, Colombo A, Scott J, Anesi S, Foster C, Nigrovic P, Nihalani-Gangwani B, Angeles-Han S, Chang P, Chang M. Age and Activity-Dependent Differences in Intraocular Immune Profile of Chronic Autoimmune Uveitis [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/age-and-activity-dependent-differences-in-intraocular-immune-profile-of-chronic-autoimmune-uveitis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-and-activity-dependent-differences-in-intraocular-immune-profile-of-chronic-autoimmune-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology